Chronic Lymphoid Leukemia
Mostrando 1-12 de 59 artigos, teses e dissertações.
-
1. Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
Abstract Introduction Hematologists deal every day with high mortality rates of acute leukemia patients. Many times these patients need Intensive Care Unit (ICU) support and some general ICU teams believe that these patients have a much greater chance of dying than patients with other pathologies. In Brazil, data related to mortality rates and ICUs for acut
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
2. A case of neurocognitive deficit strongly related to dasatinib therapy
Abstract Introduction Hematologists deal every day with high mortality rates of acute leukemia patients. Many times these patients need Intensive Care Unit (ICU) support and some general ICU teams believe that these patients have a much greater chance of dying than patients with other pathologies. In Brazil, data related to mortality rates and ICUs for acut
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
3. A case of multiple myeloma and synchronous liposarcoma
Abstract Introduction Hematologists deal every day with high mortality rates of acute leukemia patients. Many times these patients need Intensive Care Unit (ICU) support and some general ICU teams believe that these patients have a much greater chance of dying than patients with other pathologies. In Brazil, data related to mortality rates and ICUs for acut
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
4. Predictors of mortality among patients with acute leukemias admitted to an intensive care unit specialized in patients with hematological disease at a Brazilian hospital
Abstract Introduction Hematologists deal every day with high mortality rates of acute leukemia patients. Many times these patients need Intensive Care Unit (ICU) support and some general ICU teams believe that these patients have a much greater chance of dying than patients with other pathologies. In Brazil, data related to mortality rates and ICUs for acut
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
5. Clinical applications of immunoglobulin: update
Human immunoglobulin is the most used blood product in the clinical practice. Immunoglobulin applications have increased quickly since the elucidation of its immunomodulatory and antiinflammatory properties which turned this blood product into a precious tool in the treatment of numerous diseases that present with humoral immune deficiency or that cause immu
Rev. Bras. Hematol. Hemoter.. Publicado em: 2011-06
-
6. Avaliação da transfecção de células dendríticas com RNA tumoral como estratégia para indução de imunidade específica em pacientes com leucemia linfóide crônica. / Evaluation of dendritic cell transfection with tumor RNA as a strategy to induce specific immunity in chronic lymphoid leukemia patients.
O desenvolvimento da imunoterapia do câncer baseada em células dendríticas (DCs) é alvo de vários estudos. Para tumores sólidos, a abordagem baseada no uso de DCs alogenêicas fundidas com células tumorais tem se mostrado relativamente eficaz. Por outro lado, esta estratégia necessita uma massa tumoral considerável de cada paciente para a geração
Publicado em: 2010
-
7. Perfil ClÃnico e Laboratorial dos Pacientes com Leucemia Linfoide CrÃnica Atendidos no ServiÃo de Hematologia e Hemoterapiado HUWC-HEMOCE / Clinical and Laboratorial Profile of Patients with Chronic Lymphocytic Leukemia admitted at the hematology and hemotherapy service of the University Hospital Walter CantÃdio (HUWC) and Hemotherapy and Hematology Center of Cearà (HEMOCE).
A leucemia linfocÃtica crÃnica (LLC) à a leucemia mais freqÃente nos paÃses ocidentais, ocorrendo em cerca de 30% de todas as leucemias do adulto, acometendo principalmente a populaÃÃo acima de 65 anos de idade. à caracterizada pela proliferaÃÃo clonal de linfÃcitos tipo B CD5 positivos. Do ponto de vista epidemiolÃgico, raramente à vista entre
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 03/09/2009
-
8. Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil
Methylenetetrahydrofolate reductase (MTHFR: EC 1.5.1.20) polymorphisms are associated to acute lymphoid leukemia in different populations. We used the polymerase chain reaction and the restriction fragment length polymorphism method (PCR-RFLP) to investigate MTHFR C677T and A1298C polymorphism frequencies in 67 patients with chronic myeloid leukemia (CML), 2
Genetics and Molecular Biology. Publicado em: 2008
-
9. FMNL1 : caracterização de um novo gene humano relacionado com a familia das forminas
Formins are proteins that are involved in processes such as morphogenesis, embryonic differentiation, cytokinesis, cell polarity and survival. The formins are multidomain proteins that are conserved from plants to fungi and vertebrates. A search of the ORESTES database, generated from the Human Cancer Genome Project, identified 2 ESTs that were similar to th
Publicado em: 2006
-
10. A rare case of Acute Lymphocytic Leukemia (ALL) presenting with double Philadelphia chromosome: relapse or secondary leukemia?
The Philadelphia chromosome is observed in 5% of pediatric acute lymphocytic leukemia (ALL) and in 25% to 50% of adult ALL cases, and is associated with poor prognosis. Double Ph in a hyperdiploid karyotype is common in chronic myeloid leukemia (CML), but rarely found in ALL. We report here the case of a girl diagnosed with ALL at 7 years of age. After treat
Genetics and Molecular Biology. Publicado em: 2003
-
11. Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.
The BCR/ABL gene, formed by the Philadelphia chromosome translocation (Ph1) of human chronic myelogenous leukemia, encodes an altered ABL gene product, P210. P210 is strongly implicated in the malignant process of chronic myelogenous leukemia, but it precise role is unknown. Infection of long-term bone marrow cultures enriched for B-lymphoid cell types with
-
12. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
We have investigated the frequency of p53 mutations in B- and T-cell human lymphoid malignancies, including acute lymphoblastic leukemia, the major subtypes of non-Hodgkin lymphoma, and chronic lymphocytic leukemia. p53 exons 5-9 were studied by using genomic DNA from 197 primary tumors and 27 cell lines by single-strand conformation polymorphism analysis an